Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)

NCT06225336 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment

Conditions

Microtia

Interventions

COMBINATION_PRODUCT: AUR-201

Sponsor

Auregen Biotherapeutics, SA